NASDAQ: GILD · Drug Manufacturers - General
Over the past week, Gilead Sciences (GILD) drew about 42 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 64% bullish but is far apart: News runs 86% bullish while Reddit sits at just 33%. Wall Street is more constructive, with 21 of 28 analysts rating GILD a buy.
There is little buzz around GILD this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 75% buy share sits next to a crowd that ranges from Reddit at 33% to News at 86%. No other tracker puts the two side by side.
Across 28 analysts the consensus is a Strong Buy: 21 buy calls against 1 sell, with an average 12-month price target of $157.41.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 11 points above the crowd average of 64%, the professionals are more constructive than retail. The split is inside the crowd: News reads 86% bullish while Reddit sits at 33%, a 53-point spread that single-source trackers miss.
Over the 30-day window, Gilead Sciences (GILD) buzz held moderate around 42.2 while the price drifted up 4.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.2M shares. Over the last 7 trading days, GILD lost 3.9%. Buzz activity in the recent week averaged 34.8 and was relatively stable, swinging between 29.1 and 42.2. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 17 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GILD and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GILD sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (21 / 6 / 1) |
| Crowd bullish (7d) | 64% |
| Avg price target | $157.41 |
| Most bullish source | News, 86% |
| Most bearish source | Reddit, 33% |
| Sentiment spread | 53 pts |
| Mentions (7d) | 42 |
| Market cap | $179.56B |
| P/E · Forward P/E | n/a · 14.8 |
| EPS · Beta | -$2.64 · 0.4 |
| Revenue (TTM) | $30.46B · -11% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X and News sources, Gilead Sciences (GILD) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 64% bullish across 3 active sources. Those sources contribute 42 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Gilead Sciences (GILD) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 11 tracked subreddits. The 7-day tone is 33% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bullish on Gilead Sciences (GILD), averaging 64% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 86% bullish and Reddit at 33%, a 53-point spread. On the professional side, 21 of 28 analysts rate GILD a buy.
Of the 28 analysts covering Gilead Sciences (GILD), 21 rate it a buy, 6 a hold and 1 a sell, for a strong buy consensus. The average price target is $157.41. That puts the street ahead of the crowd, which averages 64% bullish.
Gilead Sciences (GILD)'s cross-source average is bullish at 64% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. X reads 73% bullish, News reads 86% bullish and reddit coverage is the most negative at 33% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Gilead Sciences (GILD) at 64% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is reddit at 33% bullish. 3-day activity momentum is falling on News, while reddit and x activity is rising. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 28 mentions (67% of total volume). X contributes 11 mentions and Reddit contributes 3 mentions. The cross-source average is bullish at 64% bullish, while reddit and x show rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GILD's buy signal at 93/100 conviction reflects a bullish cross-source average at 64% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The GILD sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key